ACRS – Aclaris Therapeutics Inc
ACRS — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
4.57
Margin Of Safety %
Put/Call OI Ratio
0.38
EPS Next Q Diff
0.01
EPS Last/This Y
-0.06
EPS This/Next Y
-0.16
Price
3.76
Target Price
8.94
Analyst Recom
1.2
Performance Q
41.51
Upside
-283.7%
Beta
0.71
Ticker: ACRS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | ACRS | 3.38 | 0.38 | 0.00 | 11063 |
| 2026-03-10 | ACRS | 3.67 | 0.38 | 0.32 | 11113 |
| 2026-03-11 | ACRS | 3.6 | 0.38 | 0.76 | 11338 |
| 2026-03-12 | ACRS | 3.52 | 0.39 | 0.01 | 11863 |
| 2026-03-13 | ACRS | 3.51 | 0.39 | 0.01 | 11863 |
| 2026-03-17 | ACRS | 3.89 | 0.39 | 2.02 | 11977 |
| 2026-03-18 | ACRS | 3.67 | 0.41 | 0.08 | 12314 |
| 2026-03-20 | ACRS | 3.68 | 0.38 | 0.00 | 12997 |
| 2026-03-25 | ACRS | 3.59 | 0.34 | 0.32 | 10919 |
| 2026-03-26 | ACRS | 3.53 | 0.34 | 0.01 | 10954 |
| 2026-03-27 | ACRS | 3.53 | 0.34 | 100.00 | 11053 |
| 2026-03-30 | ACRS | 3.48 | 0.39 | 0.11 | 11456 |
| 2026-03-31 | ACRS | 3.74 | 0.39 | 0.00 | 11475 |
| 2026-04-01 | ACRS | 4.14 | 0.39 | 0.05 | 11480 |
| 2026-04-06 | ACRS | 3.99 | 0.38 | 0.29 | 11606 |
| 2026-04-07 | ACRS | 3.76 | 0.38 | 3.00 | 11627 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | ACRS | 3.39 | -30.0 | - | -0.60 |
| 2026-03-10 | ACRS | 3.67 | -30.0 | - | -0.60 |
| 2026-03-11 | ACRS | 3.61 | -30.0 | - | -0.60 |
| 2026-03-12 | ACRS | 3.52 | -30.0 | - | -0.60 |
| 2026-03-13 | ACRS | 3.55 | -30.0 | - | -0.60 |
| 2026-03-17 | ACRS | 3.88 | -30.0 | - | -0.60 |
| 2026-03-18 | ACRS | 3.68 | -30.0 | - | -0.60 |
| 2026-03-19 | ACRS | 3.73 | -30.0 | - | -0.60 |
| 2026-03-20 | ACRS | 3.69 | -30.0 | - | -0.60 |
| 2026-03-23 | ACRS | 3.57 | -30.0 | - | -0.59 |
| 2026-03-24 | ACRS | 3.30 | -30.0 | - | -0.59 |
| 2026-03-25 | ACRS | 3.59 | -30.0 | - | -0.59 |
| 2026-03-26 | ACRS | 3.53 | -30.0 | - | -0.59 |
| 2026-03-27 | ACRS | 3.53 | -30.0 | - | -0.59 |
| 2026-03-30 | ACRS | 3.48 | -28.3 | - | -0.59 |
| 2026-03-31 | ACRS | 3.74 | -28.3 | - | -0.59 |
| 2026-04-01 | ACRS | 4.13 | -28.3 | - | -0.59 |
| 2026-04-02 | ACRS | 4.20 | -28.3 | - | -0.59 |
| 2026-04-06 | ACRS | 3.80 | -28.3 | - | -0.59 |
| 2026-04-07 | ACRS | 3.76 | -28.3 | - | -0.59 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | ACRS | 0.00 | -3.25 | 4.75 |
| 2026-03-10 | ACRS | 0.00 | -3.25 | 4.75 |
| 2026-03-11 | ACRS | 0.00 | -3.25 | 4.63 |
| 2026-03-12 | ACRS | 0.00 | -3.25 | 4.63 |
| 2026-03-13 | ACRS | 0.00 | -3.25 | 4.63 |
| 2026-03-18 | ACRS | 0.00 | -3.25 | 4.63 |
| 2026-03-19 | ACRS | 0.00 | -3.25 | 4.63 |
| 2026-03-20 | ACRS | 0.00 | -3.25 | 4.63 |
| 2026-03-23 | ACRS | 0.00 | -3.24 | 4.63 |
| 2026-03-24 | ACRS | 0.00 | -3.24 | 4.63 |
| 2026-03-25 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-03-26 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-03-27 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-03-30 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-03-31 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-04-01 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-04-02 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-04-06 | ACRS | 0.00 | -3.24 | 4.57 |
| 2026-04-07 | ACRS | 0.00 | -3.24 | 4.57 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.16
Avg. EPS Est. Current Quarter
-0.15
Avg. EPS Est. Next Quarter
-0.15
Insider Transactions
Institutional Transactions
-3.24
Beta
0.71
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
25
Growth Score
28
Sentiment Score
98
Actual DrawDown %
87.6
Max Drawdown 5-Year %
-97.8
Target Price
8.94
P/E
Forward P/E
PEG
P/S
57.76
P/B
4.38
P/Free Cash Flow
EPS
-0.53
Average EPS Est. Cur. Y
-0.59
EPS Next Y. (Est.)
-0.75
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-829.58
Relative Volume
0.46
Return on Equity vs Sector %
-90.4
Return on Equity vs Industry %
-73.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.04
EBIT Estimation
◆
ACRS
Healthcare
$3.75
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
53.4
Range 1M
63.4%
Sup Dist
2.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-19.6%
EPS NY
-3.6%
52W%
70.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+138.4% upside
Upside
+138.4%
Quality
25
Aclaris Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 69
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States. The company product pipeline includes Bosakitug (ATI-045), an anti-thymic stromal lymphopoietin monoclonal antibody in Phase 2 trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease; ATI-2138, an potent and selective novel investigational dual inhibitor of ITK and JAK3 in Phase 2a trial for the treatment for T cell-mediated autoimmune diseases; ATI-052, a humanized anti-TSLP and anti-IL4R bispecific antibody in Phase 1b to treat various atopic, immunologic, and respiratory diseases; ATI-9494, an oral, covalent, investigational dual inhibitor of ITK and Resting Lymphocyte Kinase (TXK), and other covalent JAK-sparing ITK inhibitors to treat modulate T cell biology across various diseases; and Lepzacitinib, a soft JAK 1/3 inhibitor for the treatment of atopic dermatitis and other dermatologic conditions. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
ACRS
Latest News
—
Caricamento notizie per ACRS…
stock quote shares ACRS – Aclaris Therapeutics Inc Stock Price stock today
news today ACRS – Aclaris Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ACRS – Aclaris Therapeutics Inc yahoo finance google finance
stock history ACRS – Aclaris Therapeutics Inc invest stock market
stock prices ACRS premarket after hours
ticker ACRS fair value insiders trading